Quantcast

Latest Duloxetine Stories

2014-09-30 23:13:29

Transparency Market Research has published a new report titled "Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018" to its report database. Albany, New York (PRWEB) September 30, 2014 The market of pain management therapeutics aims at producing drugs to alleviate acute as well as chronic pain conditions, thus improving the quality of life of patients. Body pain affects a major portion of the global population,...

2014-09-27 04:21:15

DALLAS, September 27, 2014 /PRNewswire/ -- MarketOptimizer.org adds PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023 to its store. It says product launches and patent expiries to push major depressive disorder treatment market through fluctuating growth period by 2023. Complete Report Details Available @ http://www.marketoptimizer.org/pharmapoint-major-depressive-disorder-global-drug-forecast-and-market-analysis-to-2023.html ....

2014-07-15 23:07:22

MedicationDiscountCard.com offers discounts of 10-75% on fibromyalgia treatments. Margate, NJ (PRWEB) July 15, 2014 Recent surveys show that about 2% of Americans currently suffer from fibromyalgia. Most of these are women, with about 20% of new diagnoses being men or children. Fibromyalgia can present itself with many different symptoms, including sensitivity to light, odors, and noise, or more acute symptoms like facial pain and TMJ (lockjaw). On average, patients dealing with...

2014-06-26 08:27:08

Top-line results anticipated by end-of-year RALEIGH, N.C., June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial Phase 3 study of Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN). http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO The Phase 3 trial is a multicenter, randomized, double-blind, placebo-controlled study to determine the...

2014-06-12 16:25:56

BOCA RATON, Fla., June 12, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Duloxetine Delayed-release Capsules. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by its parent company, Laboratorios Dr. Esteve, S.A. Barcelona, Spain, and will be available in 20mg, 30mg and 60mg strengths. Duloxetine Delayed-release Capsules are AB rated to...

2014-05-06 08:33:33

Faster than projected enrollment moves anticipated interim analysis up to third quarter 2014 RALEIGH, N.C., May 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has randomized more than half of the planned number of patients required for its ongoing initial Phase 3 study of Clonidine Topical Gel, BDSI's proposed treatment for painful diabetic neuropathy (PDN). The intent of the study will be to demonstrate the efficacy and safety of...

2014-04-21 08:26:01

GOLDEN, Colo., April 21, 2014 /PRNewswire/ -- A survey of 1,339 people with fibromyalgia conducted by The National Pain Foundation and NationalPainReport.com, revealed that those who have used marijuana to treat their symptoms find it significantly more effective than any of the three drugs approved by the Food and Drug Administration to treat the disorder. Photo - http://photos.prnewswire.com/prnh/20140418/76548 Photo - http://photos.prnewswire.com/prnh/20140418/76547 The three drugs...

2014-04-03 08:28:55

Product has fast track designation by FDA RALEIGH, N.C., April 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy. The Phase 3 trial is a multicenter, randomized, double blind, placebo controlled study to determine the efficacy and safety of Clonidine Topical Gel in the treatment...

2014-03-25 00:23:16

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rt6msb/investigation) has announced the addition of the "Investigation Report on China Duloxetine Market" [http://www.researchandmarkets.com/research/rt6msb/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Depression is a common mood disorder that belongs to high-incidence mental...

2014-03-04 23:02:22

The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient characteristics. Mount Laurel, NJ (PRWEB) March 04, 2014 The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.